Lilly Q2 profit slumps 33% as older products lose steam
Indianapolis-based Eli Lilly and Co. posted a profit of $1.13 billion, down from $1.68 billion a year ago, and cut its full-year profit guidance.
Indianapolis-based Eli Lilly and Co. posted a profit of $1.13 billion, down from $1.68 billion a year ago, and cut its full-year profit guidance.
Indiana-based pharmaceutical testing company Inotiv Inc. disclosed late Monday that it expects to incur charges of between $7.4 million and $9.9 million for the previously announced shutdowns of two Virginia animal-breeding facilities.
As part of the settlement, Indianapolis-based Envigo will relinquish 4,000 beagles at a dog-breeding facility to the Humane Society of the United States, or HSUS.
Like a kite that has caught a stiff breeze, Eli Lilly and Co. stock is having the ride of its life. Shares in the Indianapolis-based drugmaker have soared 41% in the past 52 weeks, to about $331 each.
For the first time, a pharmaceutical company has asked for permission to sell a birth control pill over the counter in the United States.
The West Lafayette-based pharmaceutical testing company has seen its stock price soar—and later plunge—following its announcement last fall that it planned to acquire Indianapolis-based Envigo RMS LLC, which breeds and sells animals used in lab testing.
Indianapolis-based Langham Logistics is set to open a 150,000-square-foot warehouse in Whitestown to serve pharmaceutical and biotech companies—and their suppliers—who need cold storage, meaning anything from chilled space to ultra-low-temperature freezers.
The FDA also authorized Moderna’s vaccine for school-aged children and teens. Pfizer’s shots had been the only option for those ages.
An advisory panel for the Food and Drug Administration gave a thumbs-up Wednesday to vaccines from Moderna and Pfizer for children under 5. It’s the only age group not yet eligible for vaccination against the coronavirus.
A top human resources officer at Eli Lilly and Co.’s factory in New Jersey claims the drugmaker fired her in retaliation for investigating employee complaints about drug manufacturing problems and for refusing to drop the matter.
Researchers in the field of colorectal cancer are hailing the study, published Sunday in the New England Journal of Medicine, as a groundbreaking development that could lead to new treatments for other cancers as well.
The Attorney General’s office reported all 648 political subdivisions in Indiana have joined the settlement, which is part of a roughly $26 billion payout across 46 states.
Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
Germany-based Evonik announced Thursday that it will expand its pharmaceutical production facility in Lafayette. The plant will build produce lipids for mRNA-based therapies in the United States.
The Indianapolis-based drugmaker said Wednesday the project in Boone County will create up to 500 jobs in central Indiana, along with up to 1,500 temporary construction jobs.
The drug has been closely watched by medical professionals and is viewed by financial analysts as a possible blockbuster, with potential annual sales in the billions of dollars.
The pharmaceutical giant is turning heads with an experimental medicine it claims can help obese patients shed nearly a quarter of their body weight and manage diabetes.
A panel of Indiana life science experts on Friday said the state could become more competitive for large investments and jobs if it doubled down on the kind of collaborations and partnerships that other states have used to their advantage.
Eli Lilly and Co. posted profit of $1.9 billion in the first quarter, up 40%, on higher sales of COVID-19 antibodies and other key products for diabetes, cancer and arthritis.
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.